Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,605,258
+$11,038,903 QoQ
Shares Held
283,328
+481.9% QoQ
Ownership
0.553%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 317 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. VCEL ranks #42 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in VCEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,605,258 | 283,328 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,566,355 | 48,690 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $262,044 | 7,277 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $561,190 | 13,189 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $242,373 | 5,432 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $254,724 | 6,029 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $490,961 | 10,701 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $835,857 | 16,068 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $205,184 | 5,762 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $276,405 | 8,246 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $456,362 | 12,147 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $351,752 | 11,997 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $347,003 | 13,174 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $304,708 | 13,134 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $325,098 | 12,911 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $494,184 | 12,930 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $508,149 | 12,930 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $929,737 | 19,052 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $984,112 | 18,745 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $509,949 | 9,180 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $306,514 | 9,926 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $387,925 | 20,935 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $659,462 | 47,718 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,080,638 | 117,845 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||